{
    "relation": [
        [
            "",
            "Umbilical Cord Blood & Erythropoietin & Rehabilitation",
            "Erythropoietin & Rehabilitation",
            "Only Rehabilitation"
        ],
        [
            "Description",
            "Allogeneic umbilical cord blood infusion (total nucleated cells > 3x10^7/kg intravenously), Erythropoietin injection (twice a week for 4 weeks with the dosage of 500 IU/kg for 2 times intravenously and 250 IU/kg subcutaneously for 6 times), and active rehabilitation",
            "Erythropoietin injection (twice a week for 4 weeks with the dosage of 500 IU/kg for 2 times intravenously and 250 IU/kg subcutaneously for 6 times),and active rehabilitation",
            "Active rehabilitation"
        ]
    ],
    "pageTitle": "Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy - Study Results - ClinicalTrials.gov",
    "title": "",
    "url": "https://clinicaltrials.gov/ct2/show/results/NCT01193660?sect=Xef015&view=results",
    "hasHeader": true,
    "headerPosition": "MIXED",
    "tableType": "RELATION",
    "tableNum": 25,
    "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042989142.82/warc/CC-MAIN-20150728002309-00156-ip-10-236-191-2.ec2.internal.warc.gz",
    "recordEndOffset": 863453135,
    "recordOffset": 863440022,
    "tableOrientation": "VERTICAL",
    "textBeforeTable": "Reporting Groups We tried to recruit 106 subjects. Finally 105 patients were enrolled at the beginning of the overall study and none of the participants were washed out before assignment to groups. Significant events and approaches for the overall study following participant enrollment, but prior to group assignment Pre-Assignment Details Enrollment Period: May 31, 2010 through April 9, 2011 All participants were recruited at CHA Bundang Medical Center. Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations Recruitment Details \u00a0 Hide Participant Flow \u00a0 Participant Flow Biological: Umbilical Cord Blood Infusion Drug: Erythropoietin Injection Other: Active Rehabilitation Other: Placebo Umbilical Cord Blood Other: Placebo Erythropoietin Interventions: Cerebral Palsy Condition:",
    "textAfterTable": "Participant Flow: \u00a0 Overall Study \u00a0 \u00a0 Umbilical Cord Blood & Erythropoietin & Rehabilitation \u00a0 \u00a0 Erythropoietin & Rehabilitation \u00a0 \u00a0 Only Rehabilitation \u00a0 STARTED \u00a0 \u00a0 35 \u00a0 \u00a0 36 \u00a0 \u00a0 34 \u00a0 COMPLETED \u00a0 \u00a0 31 \u00a0 \u00a0 33 \u00a0 \u00a0 32 \u00a0 NOT COMPLETED \u00a0 \u00a0 4 \u00a0 \u00a0 3 \u00a0 \u00a0 2 \u00a0 Withdrawal by Subject \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 2 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 3 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 1 \u00a0 Death \u00a0 \u00a0",
    "hasKeyColumn": true,
    "keyColumnIndex": 0,
    "headerRowIndex": 0
}